Research: Chemical Engineer Leads Multidisciplinary Cancer Studies

Contrary to popular belief, tumors are not merely a collection of cancerous cells they are a whole system of malignant cells, vasculature, and interstitial space. Chemical engineer Rakesh Jain has discovered three barriers to the delivery of therapeutic agents to their targets. First, the blood supply is nonuniform. Some cells have adequate blood supply while others do not. Second, the pressure of the interstitial space is elevated throughout the tumor, causing drugs to be pushed back into the

Written byMargaret Thomas Kelso
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Contrary to popular belief, tumors are not merely a collection of cancerous cells they are a whole system of malignant cells, vasculature, and interstitial space. Chemical engineer Rakesh Jain has discovered three barriers to the delivery of therapeutic agents to their targets. First, the blood supply is nonuniform. Some cells have adequate blood supply while others do not. Second, the pressure of the interstitial space is elevated throughout the tumor, causing drugs to be pushed back into the blood vessels or washed out of the space. And third, because of the disruption of circulation, genetically engineered macromolecules must often travel large distances, taking days, weeks, or even months to reach isolated sections of the tumor. Initially, Jain used two animal tumor models for his work. One model is an isolated tumor, pioneered by then-NIH pathologist Pietro Gullino. In this model, the tumor has a single artery and a single vein. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies